- Home
- ESQ vs EYPT Comparison
ESQ vs EYPT Comparison
Compare ESQ & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESQ
- EYPT
- Stock Information
- Founded
- ESQ 2006
- EYPT 1987
- Country
- ESQ United States
- EYPT United States
- Employees
- ESQ N/A
- EYPT N/A
- Industry
- ESQ Commercial Banks
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- ESQ Finance
- EYPT Industrials
- Exchange
- ESQ Nasdaq
- EYPT Nasdaq
- Market Cap
- ESQ 525.7M
- EYPT 439.4M
- IPO Year
- ESQ 2017
- EYPT 2005
- Fundamental
- Price
- ESQ $76.50
- EYPT $8.95
- Analyst Decision
- ESQ Buy
- EYPT Strong Buy
- Analyst Count
- ESQ 4
- EYPT 8
- Target Price
- ESQ $68.00
- EYPT $27.29
- AVG Volume (30 Days)
- ESQ 24.9K
- EYPT 1.3M
- Earning Date
- ESQ 10-24-2024
- EYPT 11-07-2024
- Dividend Yield
- ESQ 0.78%
- EYPT N/A
- EPS Growth
- ESQ 2.35
- EYPT N/A
- EPS
- ESQ 4.95
- EYPT N/A
- Revenue
- ESQ $116,205,000.00
- EYPT $45,713,000.00
- Revenue This Year
- ESQ N/A
- EYPT N/A
- Revenue Next Year
- ESQ $11.52
- EYPT N/A
- P/E Ratio
- ESQ $15.45
- EYPT N/A
- Revenue Growth
- ESQ 10.32
- EYPT 7.50
- 52 Week Low
- ESQ $44.45
- EYPT $5.87
- 52 Week High
- ESQ $76.91
- EYPT $30.99
- Technical
- Relative Strength Index (RSI)
- ESQ 68.77
- EYPT 41.34
- Support Level
- ESQ $69.86
- EYPT $8.25
- Resistance Level
- ESQ $76.91
- EYPT $9.40
- Average True Range (ATR)
- ESQ 2.52
- EYPT 0.83
- MACD
- ESQ 0.10
- EYPT -0.38
- Stochastic Oscillator
- ESQ 97.03
- EYPT 17.44
About ESQ Esquire Financial Holdings Inc.
Esquire Financial Holdings Inc is a full-service commercial bank dedicated to serving the financial needs of the legal industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The Bank offers tailored products and solutions to the legal community and their clients as well as dynamic and flexible payment processing solutions to small business owners. Banking products offered for businesses and consumers include checking, savings, money market, and time deposits; a wide range of commercial and consumer loans, as well as customary banking services. The Bank operates a payment processing platform through third-party Independent Sales Organizations.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.